Delivery Order SPE2DR25D3012-SPE2DR26F4D3A
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,296.00 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) pharmaceutical product on August 28, 2025, with an ultimate completion date of August 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,633.36 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This contract was competitively awarded with no set-aside designation and employs firm fixed pricing. The delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,296.00 to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and was competitively awarded without set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages, valued at $1,301.87, with an ultimate completion date of November 18, 2025. This competitively awarded, non-set-aside contract is a firm fixed price delivery order, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The award was executed on November 17, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,823.83 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on November 5, 2025, with completion targeted for November 6, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,200.33 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packets. The contract is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and was competitively awarded without a set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.90 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $2,272.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of October 23, 2025. This non-set-aside competitive award was issued on October 22, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency has awarded a delivery order valued at $1,296.00 to AmerisourceBergen Drug Corp for testosterone 1% (25mg/2.5g) in 2.5-gram packets. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,135.95 delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packaging, with an ultimate completion date of August 29, 2025. This is a firm fixed price contract with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4D3ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,160.00 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a completion date of December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, serving as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a comprehensive global pharmaceutical support vehicle, the IDC enables AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/10/25 |